Evidence map›Paper›PMID 42125162›Full record

ArticleClinical case reports2026

Psychotic Symptoms Following Subthalamic DBS in Parkinson's Disease: Three Clinical Cases and Literature Review.

Saeed Abdollahifard, Raziyeh Rezaei, Erfan Sanaei, Fatemeh Asadi, Amirmohammad Farrokhi, Malihe Mehdinejad Haghighi, Fatemeh Khademi, Sina Sabet, Aliasghar Karimi, Ali Razmkon and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saeed AbdollahifardResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Raziyeh RezaeiResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Erfan SanaeiStudent Research Committee Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID https://orcid.org/0000-0003-3157-8764
Fatemeh AsadiFaculty of Medicine Bushehr University of Medical Sciences Bushehr Iran.
Amirmohammad FarrokhiTrauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences Shiraz Iran.
Malihe Mehdinejad HaghighiResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Fatemeh KhademiResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Sina SabetResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Aliasghar KarimiResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.
Ali RazmkonResearch Center for Neuromodulation and Pain Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0003-4498-9044
Nematollah JaafariUnité de Recherche Clinique Intersectorielle en Psychiatrie à Vocation Régionale Pierre Deniker Centre Hospitalier Henri Laborit Poitiers France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychosis may emerge after subthalamic deep brain stimulation in Parkinson's disease, regardless of prior psychiatric history. Early recognition of stimulation-related behavioral changes, careful dopaminergic adjustment, and multidisciplinary postoperative monitoring are essential to differentiate DBS-induced psychotic symptoms from disease progression and improve neuropsychiatric and functional outcomes.

Indexed as

deep brain stimulationfunctional neurosurgeryneurosurgeryParkinson's diseasepsychotic symptoms

Identifiers

PMID42125162
PMCPMC13158162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.